Modulating lipid metabolism improves tumor immunotherapy
Immunotherapy has progressed significantly in cancer treatment; however, several factors influence its outcomes. Abnormal lipid metabolism, which is frequently observed in cancers, promotes tumor proliferation, invasion, and metastasis. Li et al from the Medical Oncology Department of Chongqing Univ...
Saved in:
| Main Authors: | Yi Zhang, Yu Ping, Qiuqing Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-02-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/2/e010824.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma
by: Yu Chen, et al.
Published: (2024-07-01) -
Cancer Immunotherapy and Abnormal Lipid Metabolism
by: Wenxin JIANG, et al.
Published: (2025-05-01) -
Serine metabolism in tumor progression and immunotherapy
by: Dong Huang, et al.
Published: (2025-04-01) -
Metabolic aspects of adoptive immunotherapy of tumors
by: D. B. Kazanskiy, et al.
Published: (2017-10-01) -
Exercise Intensity Modulation of Hepatic Lipid Metabolism
by: Fábio S. Lira, et al.
Published: (2012-01-01)